Articoli aggiunti di recente ×

Non hai articoli nel carrello

  • Home /
  • Ebooks /
  • Pharmaceutical Market Access in Emerging Markets

Disponibilità: Disponibile

Pharmaceutical Market Access in Emerging Markets

Disponibile anche come

Download


Ebook Ebook

Pharmaceutical Market Access in Emerging Markets

Güvenç Koçkaya, Albert Wertheimer

Data di pubblicazione: 10/2016

ISBN: 978-88-97419-64-8

In english


The definition of Market Access was first reported by the World Trade Organization as “to open markets for trade and improve transparency, reciprocity, and non-discrimination in international trade”. Pharmaceutical Market Access is different and it could be defined as achieving the optimal price for a product or service and/or the maximum reimbursement for the approved target population with no restrictions on funding for the medical technology. By the way, Market Access is not only the market authorization, but it also includes overlapping activities like pricing, health technology assessment, formulary, and reimbursement. Market Access is one of the most important activities for pharmaceutical companies and emerging countries represent an important opportunity for launching new products. It was reported that the Compounded Average Growth Rate (CAGR) was 6.0% in the period 2011-2017, and expected sales exceeding 1.1 trillion USD by 2017 for emerging countries. Furthermore, CAGR 2008-2012 for recently launched pharmaceuticals were 9.8% for emerging countries and 1.5% for the top 8 developed countries. The Market Access processes in the most important emerging countries in the selected regions are defined in this book with the aim to help local experts, local government officers, headquarter managements, and everyone who want to learn more about healthcare system and health policies pathways of Market Access, mapping and structure of decision makers, challenges and catalyzers for Market Access in the emerging countries.

Destinatari

Payers, Manager of the Pharmaceutical Industry; Physician and Medical Students

€ 14,99

File

€ 14,99
Autori

Güvenç Koçkaya
Health Economics and Policy Association, Ankara, Turkey

Albert Wertheimer
College of Pharmacy, Nova Southeastern University, Ft. Lauderdale, FL, USA

Sommario
  • Preface
  • Introduction to the Market Access
  • Market Access in Asian countries Kally Wong
  • Market Access in South American Countries
  • Market Access in South Eastern Europe Countries
  • Market Access in North Eastern Europe Countries
  • Market Access in the United Arab Emirates and Selected Middle Eastern Countries
  • Market Access in Sub-Saharan Africa Countries
  • Market Access in Turkey
  • Comparing the Market Access and HTA process of Selected Countries
  • The Future of Market Access
  • Conclusions
Recensioni

Potresti essere interessato anche ai seguenti prodotti

Newsletter

100 domande   Aggiornamenti   aiutare   anna maria de santi   Arresto   artrosi   blaha   comunicazione   consenso informato   corsi   corso   corso fad sangue   Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete eve   de santi   diabete   Dsm v   Eco   economici   epatopatia   esercizio fisico   farmaci e parametri   farmaco   farmacoeconomi   farmacoeconomia   fr   guida   guida in stato   health   health tec   Health technology assessment. Principi, dimensioni e strumenti   iannone   KOSS’ DIAGNOSTIC CYTOLOGY AND ITS HISTOPATHOLOGIC BASES   malattie rare   medical diagnosis and treatment   medicina generale   medicina interna   medicine   metodo   neurologia   neurologiche   neurology   oltre lo specchio   Paediatric Hypertension   Pharmacoeconomics   Pharmacoeconomics: Principles and Practice   quick medical diagnosis and treatment   radiologia medica   Requisiti essenziali per il trattamento delle neoplasie ginecologiche   sangue ed emocoponenti   sindrome   sindrome metabolica   specchio   terapia intensiva aspetti generali   testo per radiologia medica   tumor   Urgenze ed emergenze in sala parto   “La comunicazione motivante nella terapia di sovrappeso e obesità. Principi e strategie pratiche  

L'azienda
Account

SEEd srl - P.IVA: 08077480013 - Via Vittorio Alfieri, 17 - 10121 Torino (Italia)

SEEd srl declina ogni responsabilità derivante da un uso improprio delle informazioni pubblicate sul sito www.edizioniseed.it.
Tali informazioni non devono essere utilizzate o interpretate come ausilio diagnostico e/o terapeutico e non devono essere intese come sostitutive del consulto del medico.